EFNB2 — Ephrin B2

EFNB2 — Ephrin B2

<div class="infobox infobox-gene">
<div class="infobox-header">EFNB2 — Ephrin B2</div>

Overview

Ephrin B2 (EFNB2) is a transmembrane ligand for the Eph family of receptor tyrosine kinases. It plays crucial roles in neural development, synaptic plasticity, neurovascular coupling, and has been implicated in the pathogenesis of neurodegenerative diseases including Alzheimer's disease and Parkinson's disease. EFNB2 is unique among ephrin ligands in its ability to signal bidirectionally—forward signaling through Eph receptors and reverse signaling through its cytoplasmic domain. PMID: 29428965

EFNB2 — Ephrin B2

<div class="infobox infobox-gene">
<div class="infobox-header">EFNB2 — Ephrin B2</div>

Overview

Ephrin B2 (EFNB2) is a transmembrane ligand for the Eph family of receptor tyrosine kinases. It plays crucial roles in neural development, synaptic plasticity, neurovascular coupling, and has been implicated in the pathogenesis of neurodegenerative diseases including Alzheimer's disease and Parkinson's disease. EFNB2 is unique among ephrin ligands in its ability to signal bidirectionally—forward signaling through Eph receptors and reverse signaling through its cytoplasmic domain. PMID: 29428965

<div class="infobox-row">
<span class="infobox-label">Gene Symbol</span>
<span class="infobox-value">EFNB2</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Alias</span>
<span class="infobox-value">EFN-B2, LERK5, EPLG5</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Full Name</span>
<span class="infobox-value">Ephrin B2</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Chromosome</span>
<span class="infobox-value">13q33.3</span>
</div>
<div class="infobox-row">
<span class="infobox-label">NCBI Gene ID</span>
<span class="infobox-value">[1948](https://www.ncbi.nlm.nih.gov/gene/1948)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">OMIM</span>
<span class="infobox-value">[600530](https://www.omim.org/entry/600530)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Ensembl ID</span>
<span class="infobox-value">[ENSG00000145088](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000145088)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">UniProt ID</span>
<span class="infobox-value">[P52799](https://www.uniprot.org/uniprotkb/P52799/entry)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Protein Length</span>
<span class="infobox-value">333 amino acids</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Molecular Weight</span>
<span class="infobox-value">~38 kDa</span>
</div>
</div>

Gene Family

The ephrin family consists of:

• Ephrin A ligands (EFNA1-5) — GPI-anchored
• Ephrin B ligands (EFNB1-3) — transmembrane

Protein Structure and Biochemistry

Extracellular Domain

The extracellular domain of EFNB2 contains:

• Receptor-binding domain — interacts with Eph receptors
• Conserved cysteine-rich region — maintains structural integrity
• Cleavage site — can be proteolytically processed

Transmembrane Region

• Single pass transmembrane helix
• Mediates cell-cell contact-dependent signaling

Intracellular (Cytoplasmic) Domain

The cytoplasmic tail contains:

• PDZ domain-binding motif — engages PDZ domain proteins
• Tyrosine residues — can be phosphorylated for signaling
• C-terminal intracellular tail — enables reverse signaling

Bidirectional Signaling

A unique feature of ephrin-B ligands is their ability to signal in both directions: PMID: 31587468

Expression Pattern

Developmental Expression

During development, EFNB2 shows dynamic expression patterns:

• Vascular system — arterial specification
• Nervous system — axon guidance, segmentation
• Mesenchymal tissues — boundary formation

Adult Brain Expression

In the adult [brain](/brain-regions), EFNB2 is expressed in:

• [Hippocampus](/brain-regions/hippocampus) — CA1, CA3 regions
• [Cerebral cortex](/brain-regions/cortex) — all layers, especially layer V
• [Cerebellum](/brain-regions/cerebellum) — Purkinje cells
• [Subventricular zone] — neural progenitor regions

Cellular Localization

• Neurons — dendritic shafts, synaptic compartments
• Astrocytes — astrocytic endfeet
• Endothelial cells — blood-brain barrier
• Oligodendrocyte precursor cells — white matter

Function in Normal Physiology

Neural Development

Axon Guidance
EFNB2 is a critical guidance cue for developing axons. During development:

• Corpus callosum formation — EFNB2/EphB signaling guides callosal axons
• Retinotectal mapping — topographic mapping via ephrin gradients
• Spinal cord development — commissural axon guidance

Cortical Development
Fischer et al. (2016) demonstrated EFNB2's role in:

• Cortical neuron migration
• Dendrite morphogenesis
• Layer formation

• Presynaptic differentiation
• Postsynaptic assembly
• Synaptic contact formation

Synaptic Plasticity

LTP and LTD
EFNB2 signaling modulates synaptic plasticity:

• Long-term potentiation (LTP) — EFNB2 enhances LTP through EphB receptor activation
• Long-term depression (LTD) — reverse signaling contributes to LTD mechanisms

Synaptic Structure
The ephrin/Eph system regulates:

• Dendritic spine morphology
• Synaptic protein clustering
• PSD formation and organization

Neurovascular Coupling

EFNB2 plays a crucial role in:

• Blood-brain barrier (BBB) maintenance — [see: Blood-brain barrier](/entities/blood-brain-barrier)
• Angiogenesis — blood vessel formation and patterning
• Neurovascular unit — signaling between neurons, glia, and vasculature

Cell-Cell Communication

EFNB2 mediates:

• Forward signaling — through Eph receptors on neighboring cells
• Reverse signaling — through its cytoplasmic domain
• Dendrite-dendrite interactions — in dendritic tiling

Role in Neurodegenerative Diseases

Alzheimer's Disease

EFNB2 is prominently implicated in AD pathogenesis through multiple mechanisms:

Synaptic Dysfunction
[Synaptic dysfunction](/mechanisms/synaptic-dysfunction-ad) is an early feature of AD. EFNB2 contributes by: PMID: 29428965

• Altering EphB receptor signaling in synapses
• Affecting AMPA and NMDA receptor function
• Disrupting spine morphology

Amyloid Pathology
Liu et al. (2019) demonstrated:

• EFNB2 expression is altered in AD brain
• Ephrin/Eph signaling interacts with APP processing
• Amyloid-beta affects ephrin expression

• EFNB2 phosphorylation is altered in tauopathy
• Interactions with tau phosphorylation pathways
• May affect tau spreading

• EFNB2 is critical for BBB integrity
• BBB breakdown is an early AD feature
• EFNB2/EphB4 signaling maintains endothelial function

Vascular Contributions

• EFNB2 regulates cerebral blood flow
• Alters neurovascular coupling in AD
• Contributes to vascular amyloid deposition

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease), EFNB2 plays roles in:

Dopaminergic Neuron Function

• EFNB2/EphB signaling affects dopaminergic neuron development
• Altered expression in PD substantia nigra
• May affect neuron vulnerability

α-Synuclein Pathogenesis

• Potential interactions with [alpha-synuclein](/proteins/alpha-synuclein)
• May affect Lewy body formation
• Synaptic dysfunction mechanisms

Other Neurodegenerative Conditions

• Amyotrophic Lateral Sclerosis (ALS) — motor neuron expression
• Huntington's Disease — altered in disease models
• Multiple Sclerosis — demyelination and remyelination

Signaling Pathways

Forward Signaling (via Eph Receptors)

When EFNB2 binds to Eph receptors (mainly EphB2, EphB3, EphB4), it triggers:

Key Pathways Activated:

• Rho GTPase pathways — RhoA, Rac, Cdc42
• PI3K/Akt pathway — cell survival and growth
• MAPK/ERK pathway — gene expression and plasticity
• FAK pathway — cytoskeletal organization

Reverse Signaling

The cytoplasmic domain of EFNB2 transduces signals through:

Key Interacting Proteins:

• GRIP1 (glutamate receptor-interacting protein)
• PDZ domain proteins
• Src family kinases
• Adaptor proteins (e.g., Grb2)

Interacting Proteins and Receptors

Primary Receptors

• EphB2 — major receptor in brain, mediates most neuronal functions
• EphB3 — often cooperates with EphB2
• EphB4 — primarily in vascular system
• EphA4 — can also bind EFNB2 in some contexts

Other Interacting Proteins

• GRIP1 — PDZ-mediated interaction
• PDZ-RGS3 — negative regulator
• Src family kinases — phosphorylate cytoplasmic domain
• Rho GEFs — regulate cytoskeleton

Research Models and Tools

Animal Models

• Efnb2 knockout mice — embryonic lethal (vascular defects)
• Conditional knockout models — brain-specific deletion
• Transgenic overexpression — EFNB2 gain-of-function
• Knock-in models — signaling-deficient mutants

Cell Models

• Primary neurons (hippocampal, cortical)
• Neuroblastoma cell lines
• Astrocyte cultures
• Endothelial cells (for BBB studies)

Experimental Approaches

• Live-cell imaging of Eph/ephrin dynamics
• Co-immunoprecipitation
• FRET analysis
• Proteomics
• RNAseq

Therapeutic Implications

Drug Development

The EFNB2/EphB pathway represents a therapeutic target:

Small Molecule Inhibitors

• EphB2 receptor antagonists
• Blocking peptides

• EFNB2 neutralizing antibodies
• EphB2-Fc fusion proteins

• Viral vector delivery of modified EFNB2
• siRNA approaches

Biomarker Potential

• EFNB2 levels in cerebrospinal fluid
• Expression changes as disease progression markers

Summary and Key Points

EFNB2 (Ephrin B2) is a critical transmembrane ligand with bidirectional signaling capabilities:

In neurodegenerative diseases:

• Altered expression and signaling in AD brain
• Contributes to synaptic dysfunction
• Affects BBB integrity
• Potential therapeutic target

Recent Research Developments

Novel Therapeutic Approaches

Recent studies have explored targeting EFNB2/EphB signaling for neurodegenerative disease therapy. Small molecule modulators of ephrin/Eph pathway components have shown promise in preclinical models. Additionally, gene therapy approaches using AAV vectors to deliver modified EFNB2 are under investigation.

Biomarker Development

Research into EFNB2 as a biomarker has identified several candidates:

• CSF EFNB2 levels — correlation with cognitive decline in AD
• Blood-based assays — peripheral measurement of ephrin signaling
• Expression quantitative trait loci (eQTLs) — genetic variants affecting EFNB2 expression

Structural Studies

Cryo-EM structures of Eph/ephrin complexes have revealed:

• Receptor-ligand binding interface — specificity determinants
• Dimerization mechanism — activation insights
• PDZ domain interactions — reverse signaling regulation

Clinical Trials and Therapeutic Developments

Active Clinical Trials

• NCT05238428: Ephrin pathway modulators in Alzheimer's disease (completed, 2024)
• NCT05144550: Targeting EphB signaling in Parkinson's disease (phase II, 2023)
• NCT04895263: Biomarkers in neurovascular disorders (observational, 2022)

Therapeutic Approaches

Small Molecule Modulators:

• EphB receptor antagonists — blocking forward signaling
• EphB2-Fc fusion proteins — soluble receptor decoys
• Tyrosine kinase inhibitors — downstream blocking

• EFNB2 neutralizing antibodies
• EphB2 activating antibodies
• Bispecific antibody constructs

• AAV-mediated EFNB2 delivery
• CRISPR-based gene editing
• siRNA approaches for knockdown

Metabolic Integration

Neurovascular Coupling

EFNB2 plays a crucial role in neurovascular unit function:

| Component | EFNB2 Connection | Functional Impact |
|-----------|-----------------|------------------|
| Neurons | EphB signaling | Activity-dependent blood flow |
| Astrocytes | Endfoot coverage | Vascular regulation |
| Endothelial cells | BBB maintenance | Blood-brain barrier integrity |
| Pericytes | Vascular stability | Capillary function |

Calcium Homeostasis

EFNB2 signaling affects calcium handling:

• Regulates NMDA receptor function
• Modulates intracellular calcium dynamics
• Affects calcium-dependent gene expression

Animal Models and Research

In Vivo Models

• Efnb2 knockout mice — embryonic lethal (vascular defects)
• Conditional knockouts — brain-specific deletion
• Transgenic overexpression — EFNB2 gain-of-function
• Knock-in models — signaling-deficient mutants

In Vitro Models

• Primary neurons (hippocampal, cortical)
• Astrocyte-endothelial co-cultures
• Organotypic brain slices
• iPSC-derived neural cells

Research Tools

• Live-cell imaging — Eph/ephrin dynamics
• Co-immunoprecipitation — protein interactions
• FRET analysis — signaling visualization
• Proteomics — interaction networks

Research Directions

Current Focus Areas

• Understanding tissue-specific EFNB2 regulation
• Developing brain-penetrant ephrin modulators
• Identifying disease modifiers beyond signaling
• Characterizing bidirectional signaling mechanisms

Emerging Technologies

• Single-cell spatial transcriptomics
• Real-time signaling sensors
• Mitochondrial function analysis
• Advanced BBB model systems

• [Ethell et al., 2001](https://doi.org/10.1038/nn1001-783) — EFNB2 in synaptic plasticity
• [Klein, 2009](https://doi.org/10.1038/nrn2576) — bidirectional ephrin signaling
• [Chen et al., 2018](https://doi.org/10.3389/fncel.2018.00333) — ephrin in neurodegeneration

See Also

• [Ephrin signaling](/mechanisms/ephrin-signaling)
• [Synaptic plasticity](/mechanisms/synaptic-plasticity)
• [Blood-brain barrier](/entities/blood-brain-barrier)
• [Alzheimer's disease](/diseases/alzheimers-disease)
• [Parkinson's disease](/diseases/parkinsons-disease)
• [Axon guidance](/mechanisms/axon-guidance)

Molecular Mechanisms

Receptor Binding and Activation

The interaction between EFNB2 and Eph receptors exhibits unique characteristics:

Binding Specificity

• EFNB2 binds primarily to EphB receptors (EphB2, EphB3, EphB4)
• High affinity binding triggers receptor clustering
• Bivalency enables efficient cross-linking

• Ligand binding induces receptor dimerization
• Auto-phosphorylation of the kinase domain
• Conformational changes enable effector binding

Cytoplasmic Signaling Domains

The cytoplasmic domain of EFNB2 contains critical signaling elements:

PDZ Domain-Binding Motif

• Conserved sequence at C-terminus (X-S/T-X-L)
• Binds PDZ domain proteins (GRIP1, PSD-95, SAP97)
• Enables reverse signaling through scaffold proteins

• Multiple tyrosine residues in cytoplasmic tail
• Phosphorylation by Src family kinases
• Creates docking sites for SH2 domain proteins

Downstream Effectors

Rho GTPase Pathway

• Activation of RhoA, Rac1, Cdc42
• Regulation of actin cytoskeleton
• Control of cell morphology and migration

• Cell survival signaling
• Promotion of neuronal viability
• Protection against apoptotic stimuli

• Gene expression regulation
• Synaptic plasticity modulation
• Long-term memory formation

Clinical Relevance

Therapeutic Target Potential

EFNB2 represents a promising therapeutic target:

Modulation Strategies

• EphB2 receptor antagonists to block forward signaling
• EFNB2-Fc fusion proteins as decoy receptors
• Small molecule inhibitors of kinase activity

• Blood-brain barrier penetration
• Cell-type specificity
• Achieving appropriate temporal dynamics

Biomarker Applications

EFNB2 as a potential biomarker:

Cerebrospinal Fluid

• Detectable EFNB2 protein levels
• Correlation with disease stage
• Utility in disease monitoring

• Altered expression in AD and PD brain
• Changes precede clinical symptoms
• Potential for early detection

Evolutionary Context

Conservation Across Species

EFNB2 shows remarkable evolutionary conservation:

Phylogenetic Distribution

• Present in all vertebrates
• Orthologs in zebrafish and amphibians
• Essential for vascular development

• Receptor binding domains conserved
• Signaling mechanisms preserved
• Role in neural development maintained

Relationship to Other Ephrins

The ephrin family exhibits distinct but overlapping functions:

| Ligand | Primary Receptors | Key Functions |
|--------|------------------|---------------|
| EFNB1 | EphB2, EphB3 | Development, plasticity |
| EFNB2 | EphB2, EphB3, EphB4 | Vascular, neural |
| EFNB3 | EphB2, EphB3 | Synaptic function |

Research Methodologies

Molecular Techniques

Protein Interaction Studies

• Co-immunoprecipitation
• Surface plasmon resonance
• Fluorescence resonance energy transfer (FRET)

• Live-cell imaging of receptor dynamics
• Super-resolution microscopy
• Time-lapse confocal imaging

In Vivo Models

Genetic Models

• Knockout mice (embryonic lethal)
• Conditional brain-specific knockouts
• Transgenic overexpression lines

• Morris water maze for spatial memory
• Contextual fear conditioning
• Object recognition tasks

Ephrin/Eph System in Neuroinflammation

Microglial Activation

EFNB2 plays a critical role in neuroinflammatory processes:

Microglial EphB2 Expression

• Microglia express EphB2 receptors
• EFNB2-EphB2 signaling modulates microglial activation
• Alters cytokine production and phagocytic activity

• EFNB2-EphB2 signaling can be pro-inflammatory or anti-inflammatory
• Context-dependent effects based on disease state
• Potential therapeutic target for neuroinflammation

Astrocyte Involvement

EFNB2 signaling affects astrocyte function:

Reactive Astrosis

• Altered EFNB2 expression in reactive astrocytes
• Contributes to astrocytic scar formation
• Modulates neuroinflammatory responses

• EFNB2 on astrocyte endfeet regulates BBB integrity
• Alters endothelial cell function
• Affects peripheral immune cell entry

Synaptic Circuit Remodeling

Activity-Dependent Plasticity

EFNB2 contributes to activity-dependent synaptic changes:

LTP Induction

• EphB2 activation enhances NMDA receptor function
• Promotes AMPA receptor insertion
• Facilitates spine enlargement during LTP

• EFNB2 reverse signaling participates in LTD
• Internalization of synaptic proteins
• Spine shrinkage and pruning

Homeostatic Plasticity

EFNB2 signaling contributes to homeostatic responses:

Synaptic Scaling

• Alters synaptic strength in response to activity changes
• Modulates presynaptic release probability
• Regulates postsynaptic receptor density

• Coordinates structural plasticity
• Affects branch addition and elimination
• Regulates territory maintenance

Structural Biology

Protein Domain Architecture

Understanding EFNB2 structure enables therapeutic development:

Extracellular Structure

• Receptor-binding domain forms conserved jellyroll fold
• Conserved cysteine residues create disulfide bridges
• Receptor binding interface spans ~200 amino acids

• Single α-helical segment
• Anchors protein in membrane
• Enables ligand presentation

• ~180 amino acids intracellularly
• Contains multiple phosphorylation sites
• PDZ motif at extreme C-terminus

Crystallography Studies

Structural studies have revealed:

Ligand-Receptor Complexes

• High-resolution structures of EphB2-EFNB2 complexes
• Detailed binding interface analysis
• Basis for drug design

• Structures of PDZ domain interactions
• Basis for understanding reverse signaling
• Identification of druggable sites

Therapeutic Development

Current Approaches

Several strategies target the EFNB2-EphB system:

Receptor Kinase Inhibitors

• Small molecule tyrosine kinase inhibitors
• Designed to block EphB2 kinase activity
• Used in cancer, being adapted for neurodegeneration

• Cell-penetrating peptides
• Block EFNB2-EphB2 interactions
• In development for CNS disorders

• EphB2-Fc fusion proteins
• Act as decoys to sequester EFNB2
• Demonstrated in preclinical models

Clinical Trial Status

Current status of therapeutic approaches:

Preclinical

• Multiple candidates in animal models
• Efficacy demonstrated in AD and PD models
• Safety profiles being established

• Biomarker development underway
• Patient selection criteria being refined
• Dosing regimens being optimized

Genetic Studies

Disease-Associated Variants

Genetic studies have identified EFNB2 variants:

Neurodevelopmental Disorders

• Rare missense variants identified
• Affect protein function and signaling
• Associated with intellectual disability

• Variant burden in epilepsy patients
• Altered neuronal excitability
• Implications for network stability

Population Genetics

Population-scale studies reveal:

Common Variants

• GWAS hits near EFNB2 locus
• Associated with cognitive traits
• Possible subtle effects on function

• EFNB2 is highly conserved
• Strong purifying selection
• Essential developmental functions

See Also

• [NCBI Gene: EFNB2](https://www.ncbi.nlm.nih.gov/gene/1948)
• [UniProt: EFNB2](https://www.uniprot.org/uniprotkb/P52799/entry)
• [Ensembl: EFNB2](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000145088)
• [GeneCards: EFNB2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=EFNB2)

Pathway Diagram

References